Hipcast

Australia & New Zealand Hip Fracture Registry

The Australian and New Zealand Hip Fracture Registry podcast to improve hip fracture care.

  1. 1d ago

    Healthy Bones After Hip Fracture: From Guidelines to Practice

    Send us Fan Mail In this episode of Hipcast, we’re joined by Dr Angela Sheu, Staff Specialist Endocrinologist at St Vincent’s Hospital Darlinghurst, Conjoint Senior Lecturer at UNSW, and Research Officer at the Victor Chang Cardiac Research Institute, alongside Professor Jacqui Close, internationally recognised orthogeriatrician and co-chair of the ANZHFR. Together, we unpack the updated Healthy Bones Australia recommendations and what they mean for clinicians caring for people after hip fracture. Angela and Jacqui discuss the persistent osteoporosis treatment gap, why the post-fracture period is a critical window for intervention, and how the latest evidence is shaping recommendations around treatment initiation and sequencing. We also explore the practical realities of implementing these guidelines across hospital and community settings, including the role of fracture liaison services, shared care, and strategies to reduce the risk of patients being lost to follow-up. Importantly, the conversation highlights that a hip fracture should be seen not only as an acute event requiring surgical management, but also as an opportunity to prevent the next fracture through timely, coordinated osteoporosis care. 🎙️ Hipcast is hosted by Dr Niamh Dove and produced by the Australian and New Zealand Hip Fracture Registry, dedicated to improving outcomes and experiences for people with hip fracture and those who care for them.

    24 min
  2. 11/16/2025

    Balancing Risks: SGLT2s, GLP-1s, and the Hip Fracture Patient

    Send us Fan Mail In this episode of Hipcast, we speak with three clinical experts about the complexities of surgical timing in hip fracture patients who are taking SGLT2 inhibitors and GLP-1 receptor agonists. Professor Jacqueline Close (Consultant Geriatrician, Prince of Wales Hospital / Neuroscience Research Australia), A/Prof Katherine Tonks (Endocrinologist, Sydney Endocrinology / St Vincent’s Hospital) and Dr Louisa Lowes (Anaesthetist and Director of Perioperative Medicine, Prince of Wales Hospital) share insights from their respective disciplines on balancing surgical urgency with medication-related risks. The discussion explores: Mechanisms and perioperative considerations of SGLT2 inhibitors and GLP-1 agonistsHow these agents influence timing and safety of hip fracture surgeryInterdisciplinary strategies to minimise perioperative complicationsPractical take-aways for clinicians🔗 Resources mentioned: Australian Diabetes Society (ADS): Peri-operative Management of Diabetes MedicationsANZCA Safety Alert: ALERT UPDATE May 2023 Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use In People with DiabetesANZCA Safety Alert: Clinical Practice Recommendations regarding patients taking GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists prior to anaesthesia or sedation for surgical and endoscopic procedures.Australian and New Zealand Hip Fracture Registry (ANZHFR): Clinical Care Standards and Annual ReportA/Prof Katherine Tonks resource: Is your patient on a SGLT-2 Inhibitor?ANZCA Patient Instructions: Preparing for your medical procedure when taking some diabetes and/or weight loss medications🎙️ Hipcast is hosted by Dr Niamh Dove and produced by the Australian and New Zealand Hip Fracture Registry, dedicated to improving outcomes and experiences for people with hip fracture and those who care for them.

    27 min

About

The Australian and New Zealand Hip Fracture Registry podcast to improve hip fracture care.